BLLN
BLLN
Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.
Insider Buys
0
$0
Insider Sales
8
$11.64M
Total Volume
$11.64M
28 transactions
Net Activity
$11.64M
Net selling
Sentiment Rating
Heavy DistributionCEO Conviction Index
Liquidating / Profit Taking
Key Drivers
- •Heavy distribution: sales represent 100% of total transaction value.
- •CEO selling activity detected. Often driven by option expiration or diversification plans.
- •Significant liquidation: total sale value exceeds $10M.
Score Methodology
The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:
- +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
- +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
- +15CEO Buying: CEO committing own capital shows high conviction.
- +10CFO Buying: CFO purchasing shares shows financial alignment.
Atay Oguzhan
COB, CEO
$8.87M total
Tsao David
CTO
$2.60M total
Ten Bosch John Roderick
SVP of Laboratory Operations
$170K total
Multiple Insiders
S - Sale+OE Insiders
$70K total
Quick Actions
BLLN has an insider buy conviction of 0%, compared to the Unknown sector buy average of 6%. BLLN ranks #162 in insider activity out of 569 tracked companies in its industry.
Over the last 90 days, corporate insiders at BLLN (BLLN) engaged in a total of 28 transactions reported via SEC Form 4 filings. Among these, 0 were open-market purchases and 8 were sales. The total volume of insider trading reached $11.64M.
The net insider activity for BLLN shows a net selling bias of $11.64M. This activity represents a 0% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.
The most notable individual transaction was a Sale by Atay Oguzhan (COB, CEO), who traded 30.3K shares valued at $3.33M on Nov 2, 2026.
BillionToOne (BLLN) Surpasses Q3 Earnings and Revenue Estimates
Top 3 Health Care Stocks That May Explode In Q4
BLLN INVESTOR ALERT: Investigation of BillionToOne, Inc. Announced by Holzer & Holzer, LLC
BillionToOne Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into BillionToOne (BLLN)
BillionToOne falls after Fuzzy Panda Research short report
BillionToOne Responds to Inaccurate and Misleading Short Seller Report
FAQs About BLLN Insider Trading
Answers to common questions regarding corporate filings and executive sentiment for BLLN.